<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="research-article" dtd-version="1.1d1" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher">Problems of Social Hygiene, Public Health and History of Medicine</journal-id><journal-title-group><journal-title>Problems of Social Hygiene, Public Health and History of Medicine</journal-title></journal-title-group><issn publication-format="print">0869-866X</issn><issn publication-format="electronic">2412-2106</issn><publisher><publisher-name>Joint-Stock Company Chicot</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">2337</article-id><article-id pub-id-type="doi">10.32687/0869-866X-2025-33-s2-1069-1074</article-id><article-categories><subj-group subj-group-type="heading"><subject>Научная статья</subject></subj-group></article-categories><title-group><article-title>Thematic priorities in oncology: analytical overview of publication trends and vectors of translational growth</article-title></title-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Alshevskaya</surname><given-names>A. A.</given-names></name><email></email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author"><name name-style="western"><surname>Aksenova</surname><given-names>E. I.</given-names></name><email></email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author"><name name-style="western"><surname>Khasanov</surname><given-names>R. Y.</given-names></name><email></email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff id="aff-1">Research Institute for Healthcare Organization and Medical Management, 115088, Moscow, Russia</aff><pub-date date-type="epub" iso-8601-date="2025-10-24" publication-format="electronic"><day>24</day><month>10</month><year>2025</year></pub-date><volume>33</volume><fpage>1069</fpage><lpage>1074</lpage><history><pub-date date-type="received" iso-8601-date="2025-10-27"><day>27</day><month>10</month><year>2025</year></pub-date></history><permissions><copyright-statement>Copyright © 1970,</copyright-statement><copyright-year>1970</copyright-year></permissions><abstract>Amid the rapid expansion of biomedical publications and the increasing complexity of the oncology research landscape, there is a growing need for a systematic analysis of thematic priorities that define global and national trajectories of scientific advancement. Oncology, as a field at the forefront of interdisciplinary innovation, spans domains from immune and cellular technologies to molecular imaging and epigenetic targets. Identifying frontier research areas that combine high scientific intensity, sustained international relevance, and translational potential is becoming a key tool for science policy and strategic planning. This study aims to map the most prominent oncology-related topics that emerged between 2021 and 2025, using data from the SciVal platform. A content-bibliometric analysis was conducted on the twenty leading thematic clusters in global oncology, followed by a comparative assessment of their representation in the Russian publication landscape. Metrics analyzed included publication output, field-weighted citation impact (FWCI), engagement dynamics, and institutional distribution. The results indicate that Russian research is contributing to several key topics, exhibiting high citation performance in niche areas such as exosomes, CAR-T therapy, radiomics, and immunotherapy for non-small cell lung cancer. However, many globally significant topics remain underrepresented in the Russian agenda, reflecting structural and human resource gaps in areas such as epigenetics, microbiome studies, precision immunomodulation, and regulated cell death mechanisms. These findings highlight both thematic gaps and institutional growth zones that require targeted support. Identifying advanced research areas positioned at the interface of scientific innovation and clinical applicability may inform the modernization of research infrastructure, the prioritization of national grant programs, and the integration of Russian research centers into global scientific consortia.</abstract><kwd-group xml:lang="en"><kwd>SciVal</kwd><kwd>FWCI</kwd><kwd>oncology</kwd><kwd>bibliometrics</kwd><kwd>thematic analysis</kwd><kwd>frontier research</kwd><kwd>immunotherapy</kwd><kwd>molecular biomarkers</kwd><kwd>digital imaging</kwd><kwd>Russian science</kwd><kwd>SciVal</kwd><kwd>publication activity</kwd><kwd>FWCI</kwd><kwd>priority areas</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>онкология</kwd><kwd>наукометрия</kwd><kwd>тематический анализ</kwd><kwd>фронтирные исследования</kwd><kwd>иммунная терапия</kwd><kwd>молекулярные биомаркеры</kwd><kwd>цифровая визуализация</kwd><kwd>российская наука</kwd><kwd>публикационная активность</kwd><kwd>приоритетные направления</kwd></kwd-group></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>Luo M., Yang W., Bai L. et al. Artificial intelligence for life sciences: a comprehensive guide and future trends // The Innovation Life. 2024. Vol. 2, N 4. P. 100105. DOI: 10.59717/j.xinn-life.2024.100105</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>Collins G., Stewart M., McKelvey B. et al. Breakthrough therapy designation criteria identify drugs that improve clinical outcomes for patients: a case for more streamlined coverage of promising therapies // Clin. Cancer Res. 2023. Vol. 29, N 13. P. 2371—2374. DOI: 10.1158/1078-0432.CCR-22-0983</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>Schmutz A., Salignat C., Plotkina D. et al. Mapping the global cancer research funding landscape // JNCI Cancer Spectr. 2019. Vol. 3, N 4. P. pkz069. DOI: 10.1093/jncics/pkz069</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>García Garza M. F., Gutiérrez Treviño O., Hashmi S. K. et al. Landscape of global pediatric oncology publications: a cross-sectional analysis // JCO Glob. Oncol. 2025. Vol. 11. P. e2400320. DOI: 10.1200/GO-24-00320</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>Альшевская А. А., Хасанов Р. Ю. Прорывные технологии в онкологии: глобальные тренды и российский контекст: экспертный обзор. М.; 2025.</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>Horvat N., Papanikolaou N., Koh D. M. Radiomics beyond the hype: a critical evaluation toward oncologic clinical use // Radiol. Artif. Intell. 2024. Vol. 6, N 4. P. e230437. DOI: 10.1148/ryai.230437</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>Filippi L., Urso L., Manco L. et al. Insights into pet-based radiogenomics in oncology: an updated systematic review // Eur. J. Nucl. Med. Mol. Imaging. 2025. P. 1—16. DOI: 10.1007/s00259-025-07262-7</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>Егоров Н. Е. Оценка публикационной активности ведущих университетов России // Управление наукой и наукометрия. 2025. Т. 20, №1. С. 12—25. DOI: 10.33873/2686-6706.2025.20-1.12-25</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>Coppola L., Cianflone A., Grimaldi A. M. et al. Biobanking in health care: evolution and future directions // J. Transl. Med. 2019. Vol. 17, N 1. P. 172. DOI: 10.1186/s12967-019-1922-3</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>Гаряев Г. А., Балаева Д. А., Рыжкин С. А. и др. Доступность онкологической медицинской помощи в Российской Федерации в контексте радиотерапии. Анализ последних лет // Проблемы социальной гигиены, здравоохранения и истории медицины. 2024. Т. 32, №5. С. 946—952. DOI: 10.32687/0869-866X-2024-32-5-946-952</mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation>Гусаров М. В., Тайц Б. М., Баринова А. Н. Актуальные вопросы совершенствования организации скрининга новообразований кожи в амбулаторных условиях // Проблемы социальной гигиены, здравоохранения и истории медицины. 2024. Т. 32, №1. С. 83—88. DOI: 10.32687/0869-866X-2024-32-1-83-88</mixed-citation></ref></ref-list></back></article>
